您的购物车当前为空
别名 TAK-677, TAK677, TAK 677, AD-9677, AD9677, AD 9677
Rafabegron (TAK677) 是一种强效的选择性 β3 肾上腺素能受体激动剂,可用于研究糖尿病和肥胖。


为众多的药物研发团队赋能,
让新药发现更简单!
Rafabegron (TAK677) 是一种强效的选择性 β3 肾上腺素能受体激动剂,可用于研究糖尿病和肥胖。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,990 | In Stock | |
| 5 mg | ¥ 4,890 | In Stock | |
| 10 mg | ¥ 6,980 | In Stock | |
| 25 mg | ¥ 9,870 | In Stock | |
| 50 mg | ¥ 13,900 | In Stock | |
| 100 mg | ¥ 18,800 | In Stock |
Rafabegron 相关产品
| 产品描述 | Rafabegron (TAK677) is a potent and selective β3 adrenergic receptor agonist for the study of diabetes and obesity. |
| 别名 | TAK-677, TAK677, TAK 677, AD-9677, AD9677, AD 9677 |
| 分子量 | 402.87 |
| 分子式 | C21H23ClN2O4 |
| CAS No. | 244081-42-3 |
| Smiles | O(CC(O)=O)C1=C2C(C(C[C@H](NC[C@H](O)C3=CC(Cl)=CC=C3)C)=CN2)=CC=C1 |
| 密度 | 1.345g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (111.7 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容